Cellromax Science Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Cellromax Science General Information

Description

Developer of a digital platform designed to create products that benefit people's health and lives. The company's platform uses carefully selected quality raw materials through partnerships with internationally recognized global companies, enabling clients to have nature-friendly ingredients carefully selected for disease care and skin aesthetics.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 357 Guseong-ro, Giheung-gu
  • Gyeonggi-do, Yongin Techno Valley, Building D, Room 710
  • Yongin-si, Gyeonggi
  • South Korea
+82
Primary Industry
Information Services (B2C)
Other Industries
Other Healthcare Services
Corporate Office
  • 357 Guseong-ro, Giheung-gu
  • Gyeonggi-do, Yongin Techno Valley, Building D, Room 710
  • Yongin-si, Gyeonggi
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellromax Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 26-Nov-2024 Completed Generating Revenue
1. Seed Round Completed Generating Revenue
To view Cellromax Science’s complete valuation and funding history, request access »

Cellromax Science Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
ubiQuoss Investment Corporate Venture Capital Minority
To view Cellromax Science’s complete investors history, request access »

Cellromax Science Acquisitions (1)

Cellromax Science’s most recent deal was a Merger/Acquisition with Hanwha Plus No 3 Special Purpose Acquisition. The deal was made on 26-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hanwha Plus No 3 Special Purpose Acquisition 26-Nov-2024 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Cellromax Science’s complete acquisitions history, request access »

Cellromax Science FAQs

  • When was Cellromax Science founded?

    Cellromax Science was founded in 2014.

  • Where is Cellromax Science headquartered?

    Cellromax Science is headquartered in Yongin-si, South Korea.

  • What industry is Cellromax Science in?

    Cellromax Science’s primary industry is Information Services (B2C).

  • Is Cellromax Science a private or public company?

    Cellromax Science is a Private company.

  • What is Cellromax Science’s current revenue?

    The current revenue for Cellromax Science is .

  • Who are Cellromax Science’s investors?

    ubiQuoss Investment has invested in Cellromax Science.

  • When was Cellromax Science acquired?

    Cellromax Science was acquired on 26-Nov-2024.

  • Who acquired Cellromax Science?

    Cellromax Science was acquired by Hanwha Plus No 3 Special Purpose Acquisition.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process